CN102697045A - Healthcare product capable of promoting red blood cell growth - Google Patents
Healthcare product capable of promoting red blood cell growth Download PDFInfo
- Publication number
- CN102697045A CN102697045A CN2012101899307A CN201210189930A CN102697045A CN 102697045 A CN102697045 A CN 102697045A CN 2012101899307 A CN2012101899307 A CN 2012101899307A CN 201210189930 A CN201210189930 A CN 201210189930A CN 102697045 A CN102697045 A CN 102697045A
- Authority
- CN
- China
- Prior art keywords
- vitamin
- red blood
- blood cell
- cell growth
- healthcare
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
The invention relates to the technical field of healthcare medicine and food, in particular to a healthcare product capable of promoting red blood cell growth. The healthcare product capable of promoting red blood cell growth is prepared by using certain proportions of vitamin B1, vitamin B, vitamin B6, vitamin B12, calcium pantothenate, folic acid, calcium carbonate, calcium phosphate, saccharomycetes, alfalfa, watercress, lysine, phospholipids, inositol and whey powder, contains various natural plants, vitamins and minerals, can enhance the functions of an immune system and a nerve system, can promote the production of red blood cells, can prevent iron-deficiency anemia, has a good healthcare and curative effect to erythropenia caused by various reasons, does not has an irritation effect to intestines and stomachs, can be rapidly absorbed by the intestines and stomachs, has a remarkable effect, is safe, does not has any toxic and side effect and can effectively relieve and cure anemia caused by erythropenia.
Description
Technical field
The present invention relates to the health medicine food technology field, refer in particular to a kind of health products that promote the red blood cell growth.
Background technology
Red blood cell or hemoglobin content are lower than the bottom line (normal person's red blood cell has more than 4,000,000 for every cubic millimeter, about per 100 milliliter of 12 gram of hemoglobin) of normal value in the blood circulation, can cause anemia; Red blood cell is made by marrow in people's the blood, and the back of reaching maturity gets into blood flow, and average life span is 120 days, therefore, some red blood cell aging deaths is all arranged every day, also has some red blood cells newly born simultaneously.If hematopoiesis function is not good enough or broken blood effect increases, all can causes red blood cell to reduce and cause anaemia.
Because red blood cell is easy to destroy, shorten life cycle, when hematopoiesis can not compensatory erythrocytic destruction and anaemia takes place.It is divided into two big types: 1, red blood cell internal factor.Relevant with heredity, as to see certain enzyme in congenital red cell defective like broad bean Huang etc. more.2, red blood cell extraneous factor.Mostly be that infection, poisoning, immune dysfunction cause.
The anaemia that the red blood cell deficiency causes, the general medicine that replenishes hematopoiesis that adopts is treated in treatment, but medicine generally can increase the weight of the intestines and stomach burden, causes to digest and assimilate badly, and has certain side effect.
Summary of the invention
The present invention is directed to the deficiency that causes anaemia to exist in drug therapy to the red blood cell deficiency at present, and a kind of health products that promote the red blood cell growth are provided, for realizing above purpose, the present invention adopts following technical scheme:
A kind of health products that promote red blood cell growth, it is following that the every dosage of said health products contains effective health therapy composition: vitamin B1 30-60mg, vitamin B2 40-65mg, vitamin B6 40-65mg, cobalamin 300-700 μ g, calcium pantothenate 35-60mg, folic acid 400-700 μ g, calcium carbonate 70-100mg, calcium phosphate 50-100mg, saccharomycete 5-15mg, alfalfa 5-15mg, watercress 5-15mg, from amino acid 5-15mg, phosphatidase 11 0-25mg, inositol 40-65mg, whey powder 5-15mg.
Preferable, the deal of said each composition is: the health therapy composition of effect is following: vitamin B1 45mg, vitamin B2 45mg, vitamin B6 50mg, cobalamin 400 μ g, calcium pantothenate 40mg, folic acid 500 μ g, calcium carbonate 85mg, calcium phosphate 78mg, saccharomycete 10mg, alfalfa 10mg, watercress 10mg, from amino acid 10mg, phosphatidase 12 0mg, inositol 40mg, whey powder 10mg.
Preferable, said health products are capsule or oral liquid.
Beneficial effect of the present invention is: the health products of promotion red blood cell growth of the present invention; Comprise certain proportional quantity vitamin B1, Cobastab, vitamin B6, cobalamin, calcium pantothenate, folic acid, calcium carbonate, calcium phosphate, saccharomycete, alfalfa, watercress, form from amino acid, phosphatide, inositol, whey powder; Contain multiple natural plants and multivitamin and mineral matter; Enhance immunity system and nervous function promote blood rbc to generate, the prevention hypoferric anemia; The red blood cell that a variety of causes is caused reduces, and has the good health care curative effect; Stomach is had no stimulation, and can be by the intestines and stomach fast Absorption, effect is remarkable, and is safe, without any side effects, takes the anemia that effective alleviation and the minimizing of treatment red blood cell cause for a long time.
The specific embodiment:
Below in conjunction with specific embodiment the present invention is further specified:
Embodiment 1:
A kind of health products that promote red blood cell growth, it is following that the every dosage of said health products contains effective health therapy composition: vitamin B1 30mg, vitamin B2 65mg, vitamin B6 40mg, cobalamin 700 μ g, calcium pantothenate 35mg, folic acid 700 μ g, calcium carbonate 70mg, calcium phosphate 100mg, saccharomycete 5mg, alfalfa 15mg, watercress 5mg, from amino acid 15mg, phosphatidase 11 0mg, inositol 65mg, whey powder 5mg.
About the form of health products of the present invention, the present invention does not do concrete restriction, and those skilled in the art add the suitable additive that allows according to basic general knowledge and demand in prescription, can produce capsule, oral liquid or the like.
Embodiment 2:
Enumerate the health products of the promotion red blood cell growth of another kind of prescription in the present embodiment; It is following that the every dosage of health products contains effective health therapy composition: a kind of health products that promote red blood cell growth, it is following that the every dosage of said health products contains effective health therapy composition: vitamin B1 60mg, vitamin B2 40mg, vitamin B6 65mg, cobalamin 300 μ g, calcium pantothenate 60mg, folic acid 400 μ g, calcium carbonate 100mg, calcium phosphate 50mg, saccharomycete 15mg, alfalfa 5mg, watercress 15mg, from amino acid 5mg, phosphatidase 12 5mg, inositol 40mg, whey powder 15mg.
Embodiment 3:
As a preferred embodiment; Each composition of health products of promotion red blood cell of the present invention growth is preferable with following proportioning effect, vitamin B1 45mg, vitamin B2 45mg, vitamin B6 50mg, cobalamin 400 μ g, calcium pantothenate 40mg, folic acid 500 μ g, calcium carbonate 85mg, calcium phosphate 78mg, saccharomycete 10mg, alfalfa 10mg, watercress 10mg, from amino acid 10mg, phosphatidase 12 0mg, inositol 40mg, whey powder 10mg.
The health products of promotion red blood cell growth of the present invention are all obtained good curative effect in various degree through a lot of clinical verifications.Enumerate a case wherein at present: Zheng, woman, 37 years old, sallow complexion, tired weak, the inspection routine blood test; Red blood cell and hemochrome seriously lowly cause anaemia; Promoting erythrocyte growth of the present invention is taken in suggestion, and once a day, each dosage was taken three months continuously, the check routine blood test, and each item index is normal basically, and the anemia that red blood cell lowly causes is clearly better.
The above embodiment; It is preferred embodiments of the present invention; Be not to limit practical range of the present invention,, all should be included in the patent claim of the present invention so all equivalences of doing according to the described structure of claim of the present invention, characteristic and principle change or modify.
Claims (3)
1. health products that promote red blood cell growth; It is characterized in that it is following that the every dosage of said health products contains effective health therapy composition: vitamin B1 30-60mg, vitamin B2 40-65mg, vitamin B6 40-65mg, cobalamin 300-700g, calcium pantothenate 35-60mg, folic acid 400-700 μ g, calcium carbonate 70-100mg, calcium phosphate 50-100mg, saccharomycete 5-15mg, alfalfa 5-15mg, watercress 5-15mg, from amino acid 5-15mg, phosphatidase 11 0-25mg, inositol 40-65mg, whey powder 5-15mg.
2. a kind of health products that promote the red blood cell growth according to claim 1; It is characterized in that the deal of said each composition is: the health therapy composition of effect is following: VB14 5mg, vitamin B2 45mg, vitamin B6 50mg, cobalamin 400 μ g, calcium pantothenate 40mg, folic acid 500 μ g, calcium carbonate 85mg, calcium phosphate 78mg, saccharomycete 10mg, alfalfa 10mg, watercress 10mg, from amino acid 10mg, phosphatidase 12 0mg, inositol 40mg, whey powder 10mg.
3. a kind of health products that promote the red blood cell growth according to claim 1 and 2 is characterized in that said health products are capsule or oral liquid.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2012101899307A CN102697045B (en) | 2012-06-09 | 2012-06-09 | Healthcare product capable of promoting red blood cell growth |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2012101899307A CN102697045B (en) | 2012-06-09 | 2012-06-09 | Healthcare product capable of promoting red blood cell growth |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN102697045A true CN102697045A (en) | 2012-10-03 |
| CN102697045B CN102697045B (en) | 2013-10-23 |
Family
ID=46890339
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2012101899307A Expired - Fee Related CN102697045B (en) | 2012-06-09 | 2012-06-09 | Healthcare product capable of promoting red blood cell growth |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102697045B (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107279988A (en) * | 2017-05-16 | 2017-10-24 | 柳州联云科技有限公司 | One kind is enriched blood food and preparation method thereof |
Citations (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2001149050A (en) * | 1999-11-30 | 2001-06-05 | Kaoru Osanai | Stick containing powdery vegetables, beverage containing vegetables and production thereof |
| JP2003313134A (en) * | 2002-04-22 | 2003-11-06 | Noevir Co Ltd | Vascular endothelial growth factor production promoter |
| CN1787826A (en) * | 2003-03-11 | 2006-06-14 | 爱科来株式会社 | Supplement food for low blood glucose recovery |
| KR100874039B1 (en) * | 2007-07-12 | 2008-12-12 | 최영만 | The manufacturing method of fermented soybeans using sprouts |
| JP2008301733A (en) * | 2007-06-06 | 2008-12-18 | Murakami Noen:Kk | Iron-rich sprout and method for producing the same |
| CN101411492A (en) * | 2008-12-12 | 2009-04-22 | 楼方雨 | Purple medic and wheat flour |
| JP2009126826A (en) * | 2007-11-22 | 2009-06-11 | Atsuo Sekiyama | Anti-stress agent |
| WO2010086972A1 (en) * | 2009-01-28 | 2010-08-05 | Sekiyama Atsuo | Antistress agent |
-
2012
- 2012-06-09 CN CN2012101899307A patent/CN102697045B/en not_active Expired - Fee Related
Patent Citations (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2001149050A (en) * | 1999-11-30 | 2001-06-05 | Kaoru Osanai | Stick containing powdery vegetables, beverage containing vegetables and production thereof |
| JP2003313134A (en) * | 2002-04-22 | 2003-11-06 | Noevir Co Ltd | Vascular endothelial growth factor production promoter |
| CN1787826A (en) * | 2003-03-11 | 2006-06-14 | 爱科来株式会社 | Supplement food for low blood glucose recovery |
| JP2008301733A (en) * | 2007-06-06 | 2008-12-18 | Murakami Noen:Kk | Iron-rich sprout and method for producing the same |
| KR100874039B1 (en) * | 2007-07-12 | 2008-12-12 | 최영만 | The manufacturing method of fermented soybeans using sprouts |
| JP2009126826A (en) * | 2007-11-22 | 2009-06-11 | Atsuo Sekiyama | Anti-stress agent |
| CN101411492A (en) * | 2008-12-12 | 2009-04-22 | 楼方雨 | Purple medic and wheat flour |
| WO2010086972A1 (en) * | 2009-01-28 | 2010-08-05 | Sekiyama Atsuo | Antistress agent |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107279988A (en) * | 2017-05-16 | 2017-10-24 | 柳州联云科技有限公司 | One kind is enriched blood food and preparation method thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| CN102697045B (en) | 2013-10-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Viteri | Iron supplementation for the control of iron deficiency in populations at risk | |
| Bauernfeind | The safe use of vitamin A: a report of the International Vitamin A Consultative Group (IVACG) | |
| KR101325374B1 (en) | Oral or enteral composition useful for recovery of physical functions | |
| US6399114B2 (en) | Nutritional system for nervous system disorders | |
| CN102342913A (en) | Intra-intestinal nutrient emulsion for tumor patients and preparation method thereof | |
| Wani et al. | The other side of vitamin D therapy: a case series of acute kidney injury due to malpractice-related vitamin D intoxication | |
| CN106615690A (en) | Nutrient paste for improving pet anemia symptom, and preparation method and application thereof | |
| Anık et al. | Acute vitamin D intoxication possibly due to faulty production of a multivitamin preparation | |
| CN104413527B (en) | Composite functional beverage composition | |
| RU2665635C2 (en) | Multivitamin/mineral composition for controlling environmental stress effects; improving immunity and increasing activity, aiming at vitamin and mineral insufficiency with no negative side effects of mega-dosage food additive | |
| CN102697045B (en) | Healthcare product capable of promoting red blood cell growth | |
| Edwards et al. | Nutritional interventions for oral mucositis: a systematic literature review | |
| ES2688181T3 (en) | Composition to improve nutritional status, reduce the frequency of fever and / or increase the immune capacity of elderly people | |
| Ariff et al. | Absorbed zinc and exchangeable zinc pool size are greater in Pakistani infants receiving traditional complementary foods with zinc-fortified micronutrient powder | |
| AU2008229631A1 (en) | Body fluid supplement compositions and their use in subjects undergoing medical treatment | |
| CN103652939B (en) | Capsule with multiple vitamins C | |
| Fatima et al. | Nutritional supplements and their use in the treatment of malnutrition in developing countries | |
| CN102688416B (en) | Nutritional health-care product for improving agrypnia | |
| CN104857179A (en) | Traditional Chinese medicine composition capable of improving nutritional anemia | |
| CN103652839A (en) | Health-care capsules for enhancing human immunity and production process thereof | |
| CN102687859A (en) | Micronutrient complex health care product | |
| Mironenko et al. | Vitamin B12–description, benefits, effects on the body and the best sources | |
| TWI694830B (en) | Anemia treatment composition with multiplication effect | |
| Sevilla-Paz-Soldán et al. | Estrategia de intervención combinada para revertir la anemia ferropénica y la deficiencia en el desarrollo psicomotor en la desnutrición crónica | |
| CN101822367A (en) | Medicine combination with function of improving nutritional anemia and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C56 | Change in the name or address of the patentee | ||
| CP01 | Change in the name or title of a patent holder |
Address after: 523000 Guangdong province Dongguan city Xueyuan Road No. 150 on the third. Patentee after: Dongguan Guanghua Biotechnology Co. Ltd. Address before: 523000 Guangdong province Dongguan city Xueyuan Road No. 150 on the third. Patentee before: Dongguan Zhaoyan Biological Technology Co., Ltd. |
|
| TR01 | Transfer of patent right | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20200901 Address after: Room 401, No.223, Xingtang Dongping street, Guancheng street, Dongguan City, Guangdong Province Patentee after: Health Xingui Network Technology Co.,Ltd. Address before: 523000 Guangdong province Dongguan city Xueyuan Road No. 150 on the third. Patentee before: Dongguan Guanghua Biotechnology Co.,Ltd. |
|
| CF01 | Termination of patent right due to non-payment of annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20131023 Termination date: 20210609 |